期刊文献+

雌激素对ER阴性的子宫内膜腺癌细胞JEC增殖的作用 被引量:2

Effect of Estrogen on Growth of Estrogen Receptor Negative Endometrial Adenocarcinoma Cell Line JEC in vitro
下载PDF
导出
摘要 目的研究不同浓度的雌激素(17-βE2)对雌激素受体(ER)阴性的子宫内膜腺癌细胞系JEC增殖和细胞周期的影响。方法采用细胞计数法、四甲基偶氮唑蓝比色法(MTT)和流式细胞术(FCM)的方法,观察人子宫内膜腺癌细胞系JEC在加入17-βE2后的增殖活性和细胞周期时相变化;同时用免疫组化及图像分析,检测JEC细胞在加入17-βE2前后细胞周期调控蛋白cyclin A表达的变化。结果(1)1×10-7和1×10-6mol/L的雌激素作用JEC细胞4天后,细胞计数均明显高于对照组,而其余浓度E2无明显作用。不同浓度E2作用JEC24h、48h后,MTT法测OD值和对照组相比无明显差异;1×10-6mol/L的E2作用JEC72h后,其OD值较对照组显著增高;(2)17-βE2(1×10-6mol/L)作用JEC细胞72h后使S期及G2/M期的细胞比例增加,G0/G1期细胞比例减少。但作用48h后细胞周期时相分布无明显变化;(3)17-βE2作用JEC后可使细胞内cyclin A蛋白表达明显增加。结论一定浓度的雌激素能促进JEC细胞体外增殖,且具有剂量和时间效应性。研究提示,这种调控作用可能与cyclin A表达的变化有关。 Objective To study the effect of different concentration of estrogen(E2) on the growth of estrogen receptor negative of endometrial adenocarcinoma cell line JEC in vitro. Methods Endometrial adenocarcinoma cell line JEC originated from human endometrial adenocarcinoma was cultured in vitro. Two groups were set up: sample group (17-β estradiol at different concentrations) and control group without estrogen. The proliferative capacity of endometrial adenocarcinoma cell line JEC in the culture medium with 17-β estradiol was assessed by cell counting on a haemocytometer and evaluated by the means of 3- (4,5-dimethylthiazol z yl)-2,5-dipheny tertrazolium blue (MTT)and cell cycle was analyzed by flow cytometry (FCM). The expression of cyclin A of JEC was examined by immunocytochemical staining and using automatic image analysis technology. Results (1)The cell numbers in the fourth day after dealing with 1×10^-7and 1×10^-6 mol/L concentrations of E2were more than that in control group. The optical density of JEC cell in the 72th hour after dealing with 1 ×10^-6 mol/L concentration of E2 was higher than that in control group(P〈0. 01). There was no statistics significant difference in the other experimental groups compared with the control group(P〉0. 05). (2)FCM showed that 17-13 F4 (1×10^-6 mol/L) increased the cells percentage at the S and G2/M phases of cell cycle and decreased the cells percentage in G0/G1 phases of cell cycle. (3)Analysis on expression of intracellular cyclin A protein showed that estradiol could obviously up-regulate cyclin A protein by the immunohistochemical method of SABC. Conclusion It is suggested in the present study that estrogen can stimulate the proliferation of endometrial adenocarcinoma cell line JEC in vitro. There is an accordant dose-response and time-response relationship. In addition, its effect may be associated with the change in the expression of cyclin A.
作者 徐静 吴中明
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2009年第7期552-555,共4页 Cancer Research on Prevention and Treatment
基金 贵州省省长基金资助项目(2005:313)
关键词 子宫内膜腺癌 雌激素 eydin A Endometrial adenocarcinoma Estrogen cyclin A
  • 相关文献

参考文献10

  • 1郎景和.子宫内膜癌诊治的几个问题[J].中华妇产科杂志,2000,35(5):261-263. 被引量:116
  • 2Potischman N, Hoover RN, Brinton LA, et al. A case-control study of endogenous steroid hormones and endometrial cancer [J]. J Natl Cancer Inst, 1996,88(16) : 1127-1135.
  • 3Sherman ME, Sturgeon S, Brinton LA, et al. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas[J].Mod Pathol, 1997, 10(10) : 963-968.
  • 4吴中明,张逸群,刘祖林,李维才,何年馨,郭瑞珍,胡作怀.子宫内膜腺癌细胞系的建立及其生物学特性[J].中国肿瘤临床,1999,26(10):779-781. 被引量:10
  • 5方蓉,李芳秋,武建国.MTT比色法的条件探讨[J].临床检验杂志,2003,21(1):34-35. 被引量:66
  • 6Yoo JY, Lessor T, Hamburger AW. Inhibition of cell proliferation by 17beta-estradiol and heregulin betal in estrogen receptor negative human breast carcinoma cell lines[J]. Breast Cancer Res Treat, 1998,51(1):71-81.
  • 7Tsai EM, Wang SC, Lee JN, et al. Akt activation by estrogen in estrogen receptor-negative breast cancer cells[J]. Cancer Res, 2001,61 (23) : 8390-8392.
  • 8Chen X, Danes C, Lowe, M, et al. Activation of the estrogensignaling pathway by p21 (WAF1/CIP1) in estrogen receptornegative breast cancer cells[J]. J-Natl-Cancer-Inst,2000, 92 (17): 1403-1413.
  • 9Kyushima N, Watanabe J, Hata H, et al. Expression of cyclin A in endometrial ad and its correlation with proliferative activity and clinicopathological variables[J]. J Cancer Res Clin Oncol, 2002,128(6) :307-312.
  • 10Jenkins JK, Suwannaroj S, Elbourne KB, et al. 17-beta-estradiol alter Jurkat lymphocyte cell cyclin and induces apoptosis through suppression of bcl-2 and cyclinA[J]. Int Immunopharmacal, 2001,1 ( 1 ) : 1897-1911.

二级参考文献2

共引文献187

同被引文献17

  • 1杨淑丽,吴玉梅,孔为民,邓小虹.子宫内膜癌治疗方法的评价[J].首都医科大学学报,2005,26(5):584-587. 被引量:1
  • 2孔北华,郑文新,教授,盛修贵,张廷国,王波,杨兴升,张友忠,姜洁副,王立杰.子宫内膜癌临床问题讨论[J].现代妇产科进展,2006,15(6):401-414. 被引量:12
  • 3万伍卿.抑癌基因p21[J].国外医学(生理病理科学与临床分册),1996,16(4):262-264. 被引量:4
  • 4凌治萍.细胞生物学[M].北京:人民卫生出版社,2001:108-125.
  • 5梁素美,文欣轩,方细堂.结直肠癌中survivin、caspase-3、p21^(WAF1)的蛋白表达及其意义[J].肿瘤防治研究,2007,34(8):596-599. 被引量:16
  • 6Lax SF. Molecular genetic pathways in various types of endom- etrial carcinoma: from a phenotypical to a molecular 2-based classification[J]. Virchows Arch,211114,444 (3) :213-223.
  • 7Saegusa M, Okayasu I. Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis [J]. Cancer, 1998,83(1) : 111-121.
  • 8Arnett -Mansfield RL, DeFazio A, Mote PA, et al. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium[J]. J Clin Endocrinol Metab,2004,89 (3) :1429-1442.
  • 9Jenkins J K. Suwanmaroj $. Elbourne KB,et al. 17-beta-estra- diol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and eyclin A[J]. Int Immunop- harmacol,2001,1 ( 11 ) ~ 1897-1911.
  • 10Semczuk A, Miturski R, Skomra D, et al. Expression of the cell-cycle regulatory proteins(pRb, Cyclin D1, p16 INK4A and cdk4) in human endometrial cancer: correlation with clinico- pathological features[J]. Arch Gynecol Obstet, 2004,269 (2) : 104-110.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部